Severe acute respiratory syndrome coronavirus spike protein counteracts BST2‐mediated restriction of virus‐like particle release
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Severe acute respiratory syndrome coronavirus spike protein counteracts BST2‐mediated restriction of virus‐like particle release
Authors
Keywords
-
Journal
JOURNAL OF MEDICAL VIROLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-06-14
DOI
10.1002/jmv.25518
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tetherin Antagonism by HIV-1 Group M Nef Proteins
- (2016) Juan F. Arias et al. JOURNAL OF VIROLOGY
- Membrane Anchoring by a C-terminal Tryptophan Enables HIV-1 Vpu to Displace Bone Marrow Stromal Antigen 2 (BST2) from Sites of Viral Assembly
- (2015) Mary K. Lewinski et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference
- (2015) Justin K. Taylor et al. JOURNAL OF VIROLOGY
- Antagonism to human BST-2/tetherin by Sendai virus glycoproteins
- (2013) C. Bampi et al. JOURNAL OF GENERAL VIROLOGY
- BST2/CD317 counteracts human coronavirus 229E productive infection by tethering virions at the cell surface
- (2013) Shiu-Mei Wang et al. VIROLOGY
- Influenza Virus Partially Counteracts Restriction Imposed by Tetherin/BST-2
- (2012) Bastien Mangeat et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin
- (2012) Avis Dafa-Berger et al. VIROLOGY
- The Tetherin/BST-2 Coiled-Coil Ectodomain Mediates Plasma Membrane Microdomain Localization and Restriction of Particle Release
- (2011) J. Hammonds et al. JOURNAL OF VIROLOGY
- Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by tetherin
- (2011) Rie Watanabe et al. VIROLOGY
- HIV-1 Vpu Blocks Recycling and Biosynthetic Transport of the Intrinsic Immunity Factor CD317/Tetherin To Overcome the Virion Release Restriction
- (2011) S. Schmidt et al. mBio
- Self-assembly of Severe Acute Respiratory Syndrome Coronavirus Membrane Protein
- (2010) Ying-Tzu Tseng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hepatitis C Virus: Assembly and Release of Virus Particles
- (2010) Daniel M. Jones et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Infectious Lassa Virus, but Not Filoviruses, Is Restricted by BST-2/Tetherin
- (2010) Sheli R. Radoshitzky et al. JOURNAL OF VIROLOGY
- The RING-CH Ligase K5 Antagonizes Restriction of KSHV and HIV-1 Particle Release by Mediating Ubiquitin-Dependent Endosomal Degradation of Tetherin
- (2010) Claire Pardieu et al. PLoS Pathogens
- Antagonism of Tetherin Restriction of HIV-1 Release by Vpu Involves Binding and Sequestration of the Restriction Factor in a Perinuclear Compartment
- (2010) Mathieu Dubé et al. PLoS Pathogens
- Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to Cells
- (2009) David Perez-Caballero et al. CELL
- Nef Proteins from Simian Immunodeficiency Viruses Are Tetherin Antagonists
- (2009) Fengwen Zhang et al. Cell Host & Microbe
- HIV-1 Antagonism of CD317 Is Species Specific and Involves Vpu-Mediated Proteasomal Degradation of the Restriction Factor
- (2009) Christine Goffinet et al. Cell Host & Microbe
- Antagonism to and Intracellular Sequestration of Human Tetherin by the Human Immunodeficiency Virus Type 2 Envelope Glycoprotein
- (2009) A. Le Tortorec et al. JOURNAL OF VIROLOGY
- Vpu Directs the Degradation of the Human Immunodeficiency Virus Restriction Factor BST-2/Tetherin via a TrCP-Dependent Mechanism
- (2009) J. L. Douglas et al. JOURNAL OF VIROLOGY
- Molecular Mechanism of BST2/Tetherin Downregulation by K5/MIR2 of Kaposi's Sarcoma-Associated Herpesvirus
- (2009) M. Mansouri et al. JOURNAL OF VIROLOGY
- Dimerization of Tetherin Is Not Essential for Its Antiviral Activity against Lassa and Marburg Viruses
- (2009) Toshie Sakuma et al. PLoS One
- Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion
- (2009) Eri Miyagi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration
- (2009) R. K. Gupta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein
- (2009) Rachel L. Kaletsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu
- (2009) Amy J Andrew et al. Retrovirology
- APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein
- (2009) Shui-Mei Wang et al. VIROLOGY
- HIV-1 Vpu Neutralizes the Antiviral Factor Tetherin/BST-2 by Binding It and Directing Its Beta-TrCP2-Dependent Degradation
- (2009) Bastien Mangeat et al. PLoS Pathogens
- Vpu Antagonizes BST-2–Mediated Restriction of HIV-1 Release via β-TrCP and Endo-Lysosomal Trafficking
- (2009) Richard S. Mitchell et al. PLoS Pathogens
- Species-Specific Activity of SIV Nef and HIV-1 Vpu in Overcoming Restriction by Tetherin/BST2
- (2009) Bin Jia et al. PLoS Pathogens
- The Interferon-Induced Protein BST-2 Restricts HIV-1 Release and Is Downregulated from the Cell Surface by the Viral Vpu Protein
- (2008) Nanette Van Damme et al. Cell Host & Microbe
- Broad-Spectrum Inhibition of Retroviral and Filoviral Particle Release by Tetherin
- (2008) N. Jouvenet et al. JOURNAL OF VIROLOGY
- Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
- (2008) Stuart J. D. Neil et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started